AlloVir Scraps Clinical Trials; Will Review Sale, Other Strategic Alternatives
By Will Feuer AlloVir, a clinical-stage cell-therapy company, said it has halted three of its late-stage clinical trials following recommendations from...
Stay updated with breaking news from Alvr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer AlloVir, a clinical-stage cell-therapy company, said it has halted three of its late-stage clinical trials following recommendations from...
Shares of AlloVir Inc. plummeted 66.6% toward their first-ever close below $1 on heavy volume in afternoon trading Friday, after the immunotherapy company...
AlloVir (NASDAQ:ALVR – Get Free Report) and Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional Ownership 47.4% of AlloVir shares […]
AlloVir (NASDAQ:ALVR – Get Free Report) and Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Earnings and Valuation This table compares AlloVir and […]
AlloVir (NASDAQ:ALVR – Get Free Report) will be announcing its earnings results on Wednesday, November 1st. AlloVir (NASDAQ:ALVR – Get Free Report) last released its earnings results on Thursday, August 3rd. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.45) by ($0.03). On average, analysts expect AlloVir to […]